03
Feb
Can Metformin cause Breast Cancer?
Metformin Recall The commonly prescribed Type 2 diabetes drug metformin was recalled on May 28, 2020, by the US Food and Drug Administration (FDA). This action was taken due to testing that showed high levels of the carcinogen N-nitrosodimethylamine (NDMA). All metformin hydrochl...
View More03
Feb
Metformin Linked to Increased Risk of Bladder Cancer
Metformin, the well-known drug often prescribed for Type 2 diabetes, was recalled by the US Food and Drug Administration (FDA) on May 28, after testing found high levels of the carcinogen N-nitrosodimethylamine (NDMA). The FDA is recalling all extended-release products containing...
View More03
Feb
Excessive levels of NDMA prompt Recalls of Metformin
Metformin, a drug frequently prescribed to patients with type 2 diabetes to manage blood glucose levels, is one of the most commonly prescribed drugs in the United States. More than 78 million prescriptions for Metformin were written in 2017, according to the Agency for Healthcar...
View More